DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-936 Cr | ₹-70 Cr | ₹1,275 Cr | ₹-24 Cr | ₹-35 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DR REDDYS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2023 | ₹-936 Cr |
Mar2022 | ₹-70 Cr |
Mar2021 | ₹1,275 Cr |
Mar2020 | ₹-24 Cr |
Mar2019 | ₹-35 Cr |
How is Net Cash Inflow / Outflow of DR REDDYS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2023 | ₹-936 Cr | Negative | |
Mar2022 | ₹-70 Cr | Negative | |
Mar2021 | ₹1,275 Cr | Positive | |
Mar2020 | ₹-24 Cr | Negative | |
Mar2019 | ₹-35 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹101,024.1 Cr | -3.7% | -1.4% | 26% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,071.0 Cr | 0.2% | -6.1% | 55.7% | Stock Analytics | |
CIPLA | ₹111,808.0 Cr | -2.5% | -5.1% | 48.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹104,300.0 Cr | -0.9% | 5% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹101,202.0 Cr | 1.8% | 2.2% | 88.6% | Stock Analytics | |
MANKIND PHARMA | ₹87,328.3 Cr | -6.6% | -6.6% | NA | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -3.7% |
-1.4% |
26% |
SENSEX | -1.4% |
-0.6% |
20.1% |
You may also like the below Video Courses